228 related articles for article (PubMed ID: 8823256)
1. Medulloblastoma: long-term results for patients treated with definitive radiation therapy during the computed tomography era.
Merchant TE; Wang MH; Haida T; Lindsley KL; Finlay J; Dunkel IJ; Rosenblum MK; Leibel SA
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):29-35. PubMed ID: 8823256
[TBL] [Abstract][Full Text] [Related]
2. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience.
Khalil EM
J Egypt Natl Canc Inst; 2008 Jun; 20(2):175-86. PubMed ID: 20029474
[TBL] [Abstract][Full Text] [Related]
3. Patterns of failure following treatment for medulloblastoma: is it necessary to treat the entire posterior fossa?
Fukunaga-Johnson N; Lee JH; Sandler HM; Robertson P; McNeil E; Goldwein JW
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):143-6. PubMed ID: 9747831
[TBL] [Abstract][Full Text] [Related]
4. Treatment results for 149 medulloblastoma patients from one institution.
Khafaga Y; Kandil AE; Jamshed A; Hassounah M; DeVol E; Gray AJ
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):501-6. PubMed ID: 8655373
[TBL] [Abstract][Full Text] [Related]
5. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
[TBL] [Abstract][Full Text] [Related]
6. Medulloblastoma: the Duke University Medical Center experience.
Hershatter BW; Halperin EC; Cox EB
Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1771-7. PubMed ID: 3759529
[TBL] [Abstract][Full Text] [Related]
7. Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival.
Hughes EN; Shillito J; Sallan SE; Loeffler JS; Cassady JR; Tarbell NJ
Cancer; 1988 May; 61(10):1992-8. PubMed ID: 3129177
[TBL] [Abstract][Full Text] [Related]
8. Medulloblastoma: time-dose relationship based on a 30-year review.
del Charco JO; Bolek TW; McCollough WM; Maria BL; Kedar A; Braylan RC; Mickle JP; Buatti JM; Mendenhall NP; Marcus RB
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):147-54. PubMed ID: 9747832
[TBL] [Abstract][Full Text] [Related]
9. Secondary manifestation of medulloblastoma: metastases and local recurrences in 66 patients.
Sure U; Bertalanffy H; Isenmann S; Brandner S; Berghorn WJ; Seeger W; Aguzzi A
Acta Neurochir (Wien); 1995; 136(3-4):117-26. PubMed ID: 8748840
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for medulloblastoma.
Jenkin D; Shabanah MA; Shail EA; Gray A; Hassounah M; Khafaga Y; Kofide A; Mustafa M; Schultz H
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):573-84. PubMed ID: 10837938
[TBL] [Abstract][Full Text] [Related]
11. Low-dose craniospinal radiation therapy for medulloblastoma.
Halberg FE; Wara WM; Fippin LF; Edwards MS; Levin VA; Davis RL; Prados MB; Wilson CB
Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):651-4. PubMed ID: 2004939
[TBL] [Abstract][Full Text] [Related]
12. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.
Taylor RE; Bailey CC; Robinson KJ; Weston CL; Walker DA; Ellison D; Ironside J; Pizer BL; Lashford LS
Eur J Cancer; 2005 Mar; 41(5):727-34. PubMed ID: 15763649
[TBL] [Abstract][Full Text] [Related]
13. Effects of radiation treatment planning and patient fixation on the results of postoperative radiotherapy of childhood medulloblastoma.
Kocsis B; Székely G; Pap L; Németh G
Strahlenther Onkol; 2003 Dec; 179(12):854-9. PubMed ID: 14652675
[TBL] [Abstract][Full Text] [Related]
14. Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old.
Kiltie AE; Lashford LS; Gattamaneni HR
Med Pediatr Oncol; 1997 May; 28(5):348-54. PubMed ID: 9121399
[TBL] [Abstract][Full Text] [Related]
15. Patterns of failure in children with medulloblastoma: effects of preirradiation chemotherapy.
Hartsell WF; Gajjar A; Heideman RL; Langston JA; Sanford RA; Walter A; Jones D; Chen G; Kun LE
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):15-24. PubMed ID: 9300735
[TBL] [Abstract][Full Text] [Related]
16. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
[TBL] [Abstract][Full Text] [Related]
17. The change in patterns of relapse in medulloblastoma.
Tarbell NJ; Loeffler JS; Silver B; Lynch E; Lavally BL; Kupsky WJ; Scott RM; Sallan SE
Cancer; 1991 Oct; 68(7):1600-4. PubMed ID: 1893359
[TBL] [Abstract][Full Text] [Related]
18. Preliminary results of conformal radiation therapy for medulloblastoma.
Merchant TE; Happersett L; Finlay JL; Leibel SA
Neuro Oncol; 1999 Jul; 1(3):177-87. PubMed ID: 11550312
[TBL] [Abstract][Full Text] [Related]
19. Protracted radiotherapy treatment duration in medulloblastoma.
Paulino AC; Wen BC; Mayr NA; Tannous R; Loew TW; Goldman FD; Meeks SL; Ryken TC; Buatti JM
Am J Clin Oncol; 2003 Feb; 26(1):55-9. PubMed ID: 12576926
[TBL] [Abstract][Full Text] [Related]
20. Pre-radiation chemotherapy for infants and poor prognosis children with medulloblastoma.
Loeffler JS; Kretschmar CS; Sallan SE; LaVally BL; Winston KR; Fischer EG; Tarbell NJ
Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):177-81. PubMed ID: 3391815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
